AVEO Pharmaceuticals Inc.

(AVEO) Trade

By |

Profile

AVEO Pharmaceuticals Inc operates as a biopharmaceutical company, which is engaged in the advancement of therapeutics for oncology and other areas of unmet medical need. The company views its operations and manages its business in the US. The firm offers products such as Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. Tivozanib is designed to optimize vascular endothelial growth factor blockade while minimizing off-target toxicities, Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity, AV-380, a humanized inhibitory monoclonal antibody for the treatment or prevention of cachexia; and the AV-353 platform for the potential treatment of pulmonary arterial hypertension.

Contact Information

Website: www.aveooncology.com
Email: aveo@argotpartners.com
Main Phone: +1 617 588-1960
Address: One Broadway
Address 2: 14th Floor
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSC
CEO: Michael P. Bailey
Employees: 19
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.95 $ -0.04 (-2.01%)
Last Price 1.95 Change $ -0.04 Change % -2.01 Tick N/A
Bid 1.95 Bid Size 100.00 Ask 2.02 Ask Size 1,000.00
Open 1.98 High 2.03 Low 1.95 Prev Close 1.99
Last Trade Volume 1.3 mi 52 Wk Hi 3.59 52 Wk Low 1.49
Market Cap 244.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 125,346,598.00 EPS (TTM) -0.26 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 72 74
Number of Buys 72 72
Number of Sells 0 2
Net Activity 11057427 11005613
Last 10 Buys Shares
David M. Mott 1,000
Peter Sonsini 1,000
Jon Sakoda 1,000
Forest Baskett 1,000
Sandell D Scott 1,000
Anthony A. Florence 1,000
Peter J. Barris 1,000
Ravi Viswanathan 1,000
Joshua Makower 1,000
Ravi Viswanathan 1,000
Last 10 Sell Shares
Matthew Dallas 1,000
Michael P. Bailey 1,000
Matthew Dallas 1,000
Joseph Vittiglio 1,000
Jeno Gyuris 1,000
Joseph Vittiglio 1,000
Jeno Gyuris 1,000
William Slichenmyer 1,000
Michael P. Bailey 1,000
David Johnston 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5.67 5.67 5.67 5.67
Standard Deviation 1.15 1.15 1.15 1.15
Date of Most Recent Estimate 05/08/18 05/08/18 05/08/18 05/08/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1